Development

Articles

Polyplus’ LipidBrick is designed to expand the scope of lipid nanoparticle formulation usage in mRNA therapeutics and vaccine development.

Polyplus Introduces Novel LNP Formulation for Use in mRNA Therapeutics

Feliza Mirasol is the science editor for 

Under a technology licensing agreement with Bhami Research Laboratory, Catalent intends to develop formulations that will allow for the delivery of high-concentration biologics subcutaneously.

Catalent Licenses Bhami Research Laboratory Technology for Biologics Formulation Development

Webcasts

ASDs by Spray Drying: Process Development & Scale-Up

Webinar Date/Time: Thu, Mar 30, 2023 11:00 AM EDT


Overcoming formulation challenges for mRNA and high-concentration proteins

Pramote Cholayudth previously was the managing director of the Professional Conference Center, Ltd. He currently is a validation consultant to Biolab Co., Ltd., in Thailand. He is the founder and manager of PM consult, cpramote2000@yahoo.com.

This article discusses the evaluation of paired content uniformity and weight variation data sets using F and T tests to ensure that batches meet compendial requirements.

Justification of Using Weight Variation Instead of Content Uniformity for Release of Relevant OSD Forms

Editor of Pharmaceutical Technology Europe

Advancements in therapeutic modalities are necessitating change in drug delivery to help negate some of the expense of development and manufacturing.

Influencing Change in Drug Delivery

Podcasts

In this episode, Ana Ladino provides an update on the acceptance of a novel excipient onto CDER’s pilot program.

Drug Solutions Podcast: Progressing Excipients Through Review

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs. 

Inhalation Vaccine Development

A look back at challenge and innovation highlights in 2022 for oral solid dosage forms, this podcast episode will review industry experts’ takes on factors driving the evolution of OSD forms as well as innovations in APIs, technology, and methodology. 

Drug Solutions Podcast: Oral Solid Dosage Forms: A Look Back at Challenges and Innovations

Sam Turner is director of Technology and Development at Capcium.

Naresh Talwar, PhD, is director of Product Development at Capcium.

Ajay Pazhayattil*, M.Pharm, DBA, Ajay.Pazhayattil@capcium.com, is vice-president, Scientific and Regulatory Affairs at Capcium.

Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration.